1-Cyclopropyl-4-nitro-1H-imidazole, 95.0%, 250mg

5,8-Dibromo-2,3-diphenylquinoxaline, 95+%, 1g

2-(5-Chloro-1H-benzo[d]imidazol-2-yl)acetic acid, 95.0%, 1g

3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 250mg

(R)-methyl 5-(6-(pivaloyloxymethyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxylate, 98%, 100mg

4-Amino-3-bromo-5-chlorobenzonitrile, 95.0%, 100mg

1-(2-Chloro-6-fluoro-benzyl)-azetidine-3-carboxylic acid 2-chloro-6-fluoro-benzyl ester, 95.0%, 500mg

(R)-3-Amino-4-phenylbutanoic acid, 95.0%, 250mg

4-Aminocyclohexanecarboxylic Acid (cis- and trans- mixture)>95.0%(GC)(T)25g

3-Bromo-4-(trifluoromethyl)benzoic acid, 95.0%, 5g

1,6-Dioxaspiro[2.5]octane, 95.0%, 100mg

2-(2-AMINOPHENYL)-4-METHYLPENTAN-2-OL, 95%, 5g

6,10-Dibenzyl-N,N'-dimethyl-N,N,N',N'-tetrakis(4-methylbenzyl)-1,4-dioxaspiro[4.5]decane-(2R,3R)-diylbis(methylammonium) Bis(tetrafluoroborate) [=(R,R)-TaDiAS-2nd]>97.0%(N)1g